Boehringer Ingelheim’s Nerandomilast Hits Home Run in Phase III FIBRONEER-ILD Trial for Progressive Pulmonary Fibrosis 2 years ago AnaIn Deals
MHRA Unveils Streamlined Clinical Trial Guidance, Enhancing Safety Reporting & Trail Oversight 2 years ago AnaIn Clinical TrialsResearch Updates
Next-Gen Weight-Loss Drugs Aim to Preserve Muscle, Redefining Obesity Treatment 2 years ago AnaIn BreakthroughsPharma Industry UpdatesTop Stories
Uvax Bio Appoints CBO Kevin O’Neill as Interim CEO Amid Strategic Transition 2 years ago AnaIn Pharma Industry UpdatesResearch Updates
Novartis Accelerates Stroke Prevention Strategy with $3.1B Acquisition of Anthos 2 years ago AnaIn DealsLeadersResearch Updates
India Poised to Become Key Hub for Early-Stage Clinical Trials: Parexel’s Strategic Expansion 2 years ago AnaIn BreakthroughsTop Stories
FDA Approves First Oral Therapy for Severe Eczema in Adolescents 2 years ago AnaIn Biopharma HighlightsBreaking NewsFDA ApprovalsLeaders
J&J Pulls the Plug on Alzheimer’s Seltorexant and Other Neuroscience Programs 2 years ago AnaIn Pharma Industry UpdatesTop Stories
Vertex Wins FDA Approval for JOURNAVX™, the First Non-Opioid Oral Pain Signal Inhibitor in Over 20 Years 2 years ago AnaIn Breaking NewsBreakthroughsFDA ApprovalsTop Stories
Funding Surge Fuels Innovation: Verdiva, Aviceda, Windward, and Colossal Secure Big Series Rounds in January 2 years ago AnaIn Biopharma HighlightsBreakthroughsDealsFunding RoundsLeadersVenture Capital
Atalanta Therapeutics Secures $97M Series B to Advance RNAi Treatments for Epilepsy and Huntington’s Disease 2 years ago AnaIn Clinical TrialsInvestmentsPartnershipsResearch UpdatesVenture Capital
Allakos Collapses After Failed Trial in Chronic Hives, Slashing Workforce by 75% 2 years ago AnaIn Clinical TrialsDealsResearch UpdatesStartupsTop Stories
Sarepta’s Gene Therapy Elevidys Shows Positive Phase III Results in Duchenne Muscular Dystrophy 2 years ago AnaIn AI & DataClinical TrialsInnovationLeaders
North America Leads January Biotech Funding Round with Nearly $2 Billion Raised, Oncology and Obesity Startups Dominate 2 years ago AnaIn Breaking NewsInvestmentsPartnershipsVenture Capital
Survey Reveals Clinicians Feel Ill-Prepared for Sex Differences in Disease Despite Frequent Observations 2 years ago AnaIn Industry ConferencesInvestmentsPeopleTop Stories
